References
- SteerCFroelichJSoutulloCAJohnsonMShawMLisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorderCNS Drugs201226869170522762726
- ErmerJHomolkaRMartinPBuckwalterMPurkayasthaJRoeschBLisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteersJ Clin Pharmacol20105091001101020173084
- WigalSBKollinsSHChildressACSquiresL311 Study GroupA 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderChild Adolesc Psychiatry Ment Health2009311719508731
- WigalTBramsMGasiorMGaoJSquiresLGiblinJ316 Study GroupRandomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment designBehav Brain Funct201063420576091
- PennickMAbsorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamineNeuropsychiatr Dis Treat2010631732720628632
- ErmerJCHaffeyMBDollWJPharmacokinetics of lisdexamfetamine dimesylate after targeted gastrointestinal release or oral administration in healthy adultsDrug Metab Dispos201240229029722039171
- KrishnanSMoncriefSAn evaluation of the cytochrome p450 inhibition potential of lisdexamfetamine in human liver microsomesDrug Metab Dispos200735118018417035599
- PennickMMetabolism of the prodrug lisdexamfetamine dimesylate in human red blood cells from normal and sickle cell disease donorsJ Drug Assess201321720
- PowersJCAsgianJLEkiciODJamesKEIrreversible inhibitors of serine, cysteine, and threonine proteasesChem Rev2002102124639475012475205
- RhoadsMLFettererRHUrbanJFJrSecretion of an aminopeptidase during transition of third- to fourth-stage larvae of Ascaris suumJ Parasitol19978357807849379278
- GrdisaMVitaleLTypes and localization of aminopeptidases in different human blood cellsInt J Biochem19912333393452044841
- GoodmanSRDaescuOKakhniashviliDGZivanicMThe proteomics and interactomics of human erythrocytesExp Biol Med (Maywood)2013238550951823856902
- AbramicMVitaleLBasic amino acids preferring broad specificity aminopeptidase from human erythrocytesBiol Chem Hoppe Seyler199237373753801515063
- LochsHMorseELAdibiSAUptake and metabolism of dipeptides by human red blood cellsBiochem J199027111331372222407
- ElloryJCSwietachPGibsonJSAmino acid transportBernhardtIElloryJCRed Cell Membrane Transport in Health and DiseaseBerlinSpringer Verlag2003303319
- JasinskiDRKrishnanSHuman pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusersJ Psychopharmacol200923441041818635707
- JasinskiDRKrishnanSAbuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuseJ Psychopharmacol200923441942719329547
- ChenLTengYXuWProgress in the development of bestatin analogues as aminopeptidases inhibitorsCurr Med Chem201118796497621254977
- JiaMRWeiTXuWFThe analgesic activity of bestatin as a potent APN inhibitorFront Neurosci201045020631848
- HitzerdSMVerbruggeSEOssenkoppeleGJansenGPetersGJPositioning of aminopeptidase inhibitors in next generation cancer therapyAmino Acids201446479380824385243
- ScornikOABotbolVCellular uptake of 3H-bestatin in tissues of mice after its intravenous injectionDrug Metab Dispos19972577988049224774